Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 60S ribosomal protein L34 pseudogene comprises non-coding DNA related by sequence to the ribosomal protein L34 (RPL34), a component of the large 60S subunit of the eukaryotic ribosome. These pseudogenes are processed DNA segments that do not encode functional protein and are dispersed throughout the genome. Pseudogenes are a common feature of ribosomal protein families and result from gene duplication and retrotransposition; they are not transcribed into functional protein and have no known biological or disease roles. The 60S ribosomal protein L34 pseudogene (ENSG00000224988) should not be confused with the canonical ribosomal protein L34 (RPL34; ENSG00000109475), which is a structural ribosomal protein, not a pseudogene, and does have cellular function in protein synthesis. The pseudogene is not functionally active, not a druggable target, and not clinically relevant for the purposes typically associated with therapeutic targets.
None. There is no mechanism, as this is not an expressed or functional target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S ribosomal protein L34 pseudogene (None commonly used for the pseudogene; "RPL34P" or similar is sometimes seen for individual pseudogenes).